Norway· NO-ID_BE22931C-9719-486C-AB38-7163AFBDB777
Constella
A linaclotide product containing linaclotide, registered in Norway by AbbVie Deutschland GmbH & Co. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Linaclotide is registered in 14 of 19 countries.
Countries holding a registration under ATC A06AX04 (linaclotide), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Linaclotide · ATC A06AX04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linaclotide costs, country by country.
Normalised to the WHO defined daily dose (0.29 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linaclotide · price per daily dose (0.29 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.73
The record
At a glance
FEST (Norway)- Active substance
- Linaclotide
- Manufacturer
- AbbVie Deutschland GmbH & Co
- Country
- Norway (NO)
- ATC code
- A06AX04
- ATC class
- Linaclotide
- Defined daily dose
- 0.29 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- gtin5016007206906
- gtin5016007206913
- no_merkevare_idID_BE22931C-9719-486C-AB38-7163AFBDB777
- no_varenummer16182490NOK 2259.7
- no_varenummer13254628NOK 728
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
66 interactions on record for linaclotide.
Graded by severity as the source publishes them — 17 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linaclotide · interactions on record
66 records
- 17 moderate
- 49 minor
Most severe, free to view
- IUP aus Plastik mit GestagenG02BA03moderate
- Levonorgestrel and ethinylestradiolG03AA07moderate
- Desogestrel and ethinylestradiolG03AA09moderate
- Drospirenone and ethinylestradiolG03AA12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Linaclotide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCONSTELLAAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- United KingdomConstella 290microgram capsulesAbbVie Ltd
- SwitzerlandConstella
- FinlandConstellaAbbVie Deutschland GmbH&Co.KG
- IrelandConstella 290 micrograms hard capsulesAbbVie Deutschland GmbH & Co. KG
- NetherlandsConstella 290 microgram harde capsulesAbbVie Deutschland GmbH & Co. KG
- PolandConstellaAbbVie Deutschland GmbH & Co. KG
- BelgiumConstella 290 µgAbbVie Deutschland
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Constella
- Iceland · Constella
- Liechtenstein · Constella
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/624e8a43-f100-4dab-aa23-eac2d64de775 GET /v1/drugs/624e8a43-f100-4dab-aa23-eac2d64de775?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Linaklotid",
"merkevare_id": "ID_BE22931C-9719-486C-AB38-7163AFBDB777",
"name_form_strength": "Constella kaps 290 mikrog",
"prescription_group": "C"
}See everything about linaclotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.